Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.

被引：0
|
作者：
Kiehl, MG
Linck, D
Schaefer-Eckart, K
Kroeger, M
Bronhaeuser, M
Blau, IW
Wandt, H
Jenke, A
Kienast, J
Armstrong, VW
Basara, N
Schroeder, H
Kraut, L
Fauser, AA
机构：
[1] Clin Hematol Oncol, BMT Unit, Idar Oberstein, Germany
[2] Clin Hematol Oncol, BMT Unit, Nurnberg, Germany
[3] Univ Hosp Munster, Clin Hematol Oncol, Munster, Germany
[4] Univ Hosp Dresden, Dept Hematol Oncol, Dresden, Germany
[5] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Hematol Oncol, D-12200 Berlin, Germany
[6] Univ Hosp Gottingen, Dept Clin Chem, Gottingen, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2650
引用
收藏
页码：716A / 716A
页数：1
相关论文
共 50 条
  • [21] UNDER-EXPOSURE TO MYCOPHENOLATE ACID (MPA) AFTER REDUCED-INTENSITY CONDITIONING REGIMEN ALLOGENEIC STEM CELL TRANSPLANTATION (RIC ALLOSCT) USING MYCOPHENOLATE MOFETIL (MMF) PLUS CYCLOSPORINE A (CSA) AS GVHD PROPHYLAXIS IS ASSOCIATED TO HIGH RISK OF GRADE
    Martinez, C.
    Millan, O.
    Rovira, M.
    Fernandez-Aviles, F.
    Suarez-Lledo, M.
    Urbano-Ispizua, A.
    Brunet, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S284 - S284
  • [22] Allogeneic peripheral blood stem cell transplantation for the treatment of leukemia: A new regimen for acute GVHD prophylaxis.
    Wang, JM
    Zhang, WP
    Song, XM
    Tong, SP
    Min, BH
    BLOOD, 2002, 100 (11) : 40A - 41A
  • [23] Sirolimus and mycophenolate mofetil as GVHD prophylaxis in allogeneic stem cell transplantation for high-risk leukaemia patients
    Schleuning, M.
    Judith, D.
    Stuebig, T.
    Jedlickova, Z.
    Funk, F.
    Heshmat, M.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S109 - S109
  • [24] A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
    B Bolwell
    R Sobecks
    B Pohlman
    S Andresen
    L Rybicki
    E Kuczkowski
    M Kalaycio
    Bone Marrow Transplantation, 2004, 34 : 621 - 625
  • [25] A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
    Bolwell, B
    Sobecks, R
    Pohlman, B
    Andresen, S
    Rybicki, L
    Kuczkowski, E
    Kalaycio, M
    BONE MARROW TRANSPLANTATION, 2004, 34 (07) : 621 - 625
  • [26] A phase I/II study of mycophenolate mofetil (MMF) in combination with cyclosporine (CSP) for prophylaxis of graft versus host disease (GVHD) after myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT): Dose escalation of MMF.
    Nash, RA
    Johnston, L
    Parker, PM
    Slattery, JT
    Storer, B
    Furlong, T
    Anasetti, C
    Appelbaum, FR
    Lloid, CM
    Blume, K
    Deeg, HJ
    Forman, SJ
    Kiem, HP
    Martin, PJ
    Schubert, M
    Witherspoon, RP
    Storb, R
    BLOOD, 2003, 102 (11) : 240A - 240A
  • [27] GVHD prophylaxis with mycophenolate mofetil and cyclosporin A after allogeneic blood stem cell transplantation. Results of a pilot study.
    Bornhauser, M
    Thiede, HM
    Schuler, U
    Thiede, C
    Ehninger, G
    BLOOD, 1997, 90 (10) : 462 - 462
  • [28] SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
    KALHS, P
    BRUGGER, S
    SCHWARZINGER, I
    GREINIX, HT
    KEIL, F
    KYRLE, PA
    KNOBL, P
    LINKESCH, W
    LECHNER, K
    BLOOD, 1994, 84 (10) : A489 - A489
  • [29] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    Kasper, C
    Sayer, HG
    Mügge, LO
    Schilling, K
    Scholl, S
    Issa, MC
    Höffken, K
    BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 65 - 69
  • [30] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    C Kasper
    H G Sayer
    L O Mügge
    K Schilling
    S Scholl
    M C Issa
    K Höffken
    Bone Marrow Transplantation, 2004, 33 : 65 - 69
12345